Eliem Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Eliem Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Eliem Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eliem Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $815k | 405k | 2.01 |
| 2025-06-30 | $474k | 383k | 1.24 |
| 2025-03-31 | $466k | 382k | 1.22 |
| 2024-12-31 | $748k | 415k | 1.80 |
| 2024-09-30 | $83k | 16k | 5.09 |
| 2024-06-30 | $16k | 2.2k | 7.11 |
| 2024-03-31 | $16k | 5.9k | 2.74 |
| 2023-09-30 | $233 | 89 | 2.63 |
| 2022-06-30 | $7.0k | 2.3k | 3.07 |
| 2022-03-31 | $14k | 1.6k | 8.47 |
| 2021-12-31 | $47k | 4.4k | 10.63 |
| 2021-09-30 | $249k | 14k | 17.95 |